EDAP Wins Big With FDA Clearance
EDAP TMS shares saw an incredible gain to close out the week after the company announced that it received clearance from the FDA for its Focal One device for the ablation of prostate tissue.
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 133
Proteostasis Therapeutics Stumbles Despite Positive Early Stage Data
Proteostasis Therapeutics saw its shares slide early on Thursday after the company reported positive data from its early stage trial in cystic fibrosis.
Pfizer Drops $600 Million in Its Venture Capital Arm
Pfizer shares were up marginally on Wednesday after the pharma giant announced that it would be committing over half a billion dollars to its venture capital arm.
What the Management Picture for CVS and Aetna Will Look Like Going Forward
CVS Health and Aetna are closing in on finalizing the acquisition, and the companies have now announced the management team going forward.
Why Axovant Shares More Than Doubled
Axovant Sciences shares more than doubled on Wednesday after the company announced a new licensing agreement.
Verrica Pharmaceuticals Closes in on IPO
Verrica Pharmaceuticals expects to price 5 million shares in the range that results in an initial public offering valued up to $92 million.
Wedbush’s Monday ASCO Roundup
The 54th annual meeting of the American Society of Clinical Oncology (ASCO) has just concluded and there were some significant moves we saw as a result.
How Deciphera Pharma Is Capitalizing Big on ASCO
Deciphera Pharmaceuticals saw its shares took a breather early Tuesday after the firm announced a secondary offering.
Mylan Wins Big With FDA Approval
Mylan saw its shares make a handy gain early on Tuesday after the FDA announced a key approval for Fulphila (pegfilgrastim-jmbd), a biosimilar to Neulasta (pegfilgrastim).
Jounce Therapeutics Sinks on ASCO Update
Jounce Therapeutics watched its shares drop sharply on Monday after the company presented preliminary data from its early stage cancer trial at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting.
Why Nektar Therapeutics Shares Are Tumbling
Nektar Therapeutics (NASDAQ: NKTR) saw its shares get nearly halved in Monday’s session after the company released preliminary data from its early stage cancer study. The preliminary results presented at the 2018 American Society…
Jefferies Analysts Out With Top Stock Picks Before Big Health Care Conference
While the health care sector as a whole has had its ups and downs, there is no question that mergers and acquisitions can spike interest in the companies fast. Many on Wall Street feel…
Biotech and Pharmaceutical Giants Go All In With Big Data Analytics
It’s no surprise that it was only a matter of time before the usage and storage of big data and analytics would come to the health care sector, and many of the top companies…
Why Positive Results Just Aren’t Good Enough for Clearside Bio
Clearside Biomedical shares were dropping early on Thursday after the company released data from its midstage clinical trial of Eylea for diabetic macular edema.
How Newsoara Bio Is Saving vTv Therapeutics
vTv Therapeutics watched its shares make a massive gain early on Thursday after the firm announced an exclusive licensing agreement with Newsoara Biopharma.